Back

Turning evidence into excellence - practical strategies for achieving Lipid-lowering therapy success post acute coronary syndrome

30 August 2025 (12:43 - 12:53)
Organised by: Logo
Congress Presentation Part of: Early escalation for intense lipid-lowering - the ultimate game-changer for atherosclerotic cardiovascular disease (ASCVD)? Lipids Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ana Lopez Suarez

Complex Public Hospital Virgen del Rocio Regional, Sevilla, Spain (Spain)

7 More presentations in this session

Presentation thumbnail
Welcome and introduction
Doctor A. Lopez Suarez (Sevilla, Spain, ES)
Video
Presentation thumbnail
The guideline gap - are we hitting the mark in post-ACS lipid management?
Professor I. Eitel (Luebeck, DE)
Video
Presentation thumbnail
siRNA/Inclisiran and the CV continuum - are we reinventing LDL-C management?
Doctor P. Taub (La Jolla, US)
Video
Presentation thumbnail
Real-world evidence or real-world reality - Is Real world evidence a mirror or magnifier of RCTs?
Professor P. Perrone-Filardi (Naples, IT)
Video
Presentation thumbnail
Early goal attainment or long-term retention - what drives better patient outcomes?
Professor P. Perrone-Filardi (Naples, IT) Doctor P. Taub (La Jolla, US)
Video

Access the full session

Session thumbnail
Early escalation for intense lipid-lowering - the ultimate game-changer for atherosclerotic cardiovascular disease (ASCVD)?
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 12:43 CET
You may be interested in
thumbnail
Congress Session
For high-risk patients it's 15 minutes to midnight on the acute coronary syndrome (ACS) clock: can we stop it?
31 August 2024
thumbnail
Congress Presentation
Tailoring the clinical approach: who will benefit from innovative lipid-lowering therapies?
1 September 2024
thumbnail
Congress Session
Beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon
28 August 2023
thumbnail
Congress Presentation
Clinical consequences of the lipid-lowering treatment in patients with acute coronary syndrome: real-world retrospective study (LipidACS study)
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources